FDA Inspection
VitalantVitalant – FDA Inspection, Sep 18, 2013
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on September 18, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- September 18, 2013
- Product Type
- Biologics
View Company Profile
ID · e5ccbc36-9dd3-44a6-bdb6-c439a6be404d
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 848922
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 6, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 14, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 26, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Vitalant
- FDA Inspection 1115247 - 2019-11-05
- FDA Inspection 1049590 - 2018-04-06
- FDA Inspection 986765 - 2016-09-14
- FDA Inspection 743495 - 2011-08-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.